116
Participants
Start Date
April 1, 2017
Primary Completion Date
November 19, 2019
Study Completion Date
November 19, 2019
YRA-1909 low dose
A low dose of YRA-1909; daily oral intake for 12 weeks
YRA-1909 mid dose
A mid dose of YRA-1909; daily oral intake for 12 weeks
YRA-1909 high dose
A high dose of YRA-1909; daily oral intake for 12 weeks
Placebo
Matching placebo dosing with daily oral intake for 12 weeks
Seoul National University Hospital, Seoul
Hanllym University Medical Center, Anyang
Chungbuk National University Hospital, Chungju
Kelmyung University Dongsan Medical Center, Daegu
Chungnam National University Hospital, Daejeon
Kyung Hee University Hospital at Gangdong, Gangdong
Chonnam National University Hospital, Gwangju
Gachon University Gil Medical Center, Incheon
Chonbuk National University Hospital, Jeonju
Seoul National University Bundang Hospital, Seongnam
Hanyang University Seoul Hospital, Seoul
KyungHee University Hospital, Seoul
Seoul Metropolitan Goverment Seoul National Univeersity Boramae Medical Center, Seoul
Ajou University Hospital, Suwon
Yungjin Pharm. Co., Ltd.
INDUSTRY